Results 41 to 50 of about 746,035 (174)
, 2019 Correlations between meibomian gland dysfunction and ocular surface parameters according to pterygium grades (1–4).
Bruna Duarte (7378040) +5 more
core +1 more source
, 2023 Meibomian gland dysfunction is the most common cause of dry eye disease and leads to significantly reduced quality of life and social burdens. Because meibomian gland dysfunction results in impaired function of the tear film lipid layer, studying the ...
Jensen, Janicke L. +10 more
core +1 more source
A novel method of complex evaluation of meibomian glands morphological and functional state
Oftalʹmologiâ, 2014 A novel method that provides complex assessment of meibomian glands morphological and functional state — biometry of meibomian glands — was developed. The results of complex examination (including meibomian glands biometry), correlation analysis data and
V. N. Trubilin +4 more
doaj +3 more sources
Journal of Dr. NTR University of Health SciencesPurpose: To evaluate changes in meibomian gland function before and after cataract surgery, comparing outcomes between Small Incision Cataract Surgery (SICS) and Phacoemulsification (PHACO).
Kamireddy Krishna Priya +3 more
doaj +1 more source
Frontiers in Neuroscience, 2022 ObjectiveTo investigate voxel-based morphometry (VBM) by using magnetic resonance imaging (MRI) in meibomian gland dysfunction patients with severe obesity (PATs) and to explore the application of VBM in the early diagnosis, prevention of cognitive ...
Le-Yan Li +12 more
doaj +1 more source
Ocular Manifestations of Metabolic Syndrome: A Systemic Vascular Phenotype
Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9809-9818, November 2026.ABSTRACT Context Metabolic syndrome (MetS) is defined by central obesity, insulin resistance, hypertension and dyslipidemia. MetS affects over one‐third of US adults. Beyond its cardiovascular burden, MetS has clinically relevant associations with ocular health and may contribute to a systemic vascular and neuro‐metabolic phenotype involving the retina,
Ron T. Varghese, Ansu A. John
wiley +1 more source
Efficacy of Topical N-Acetylcysteine in the Treatment of Meibomian Gland Dysfunction
, 2010 Purpose: To evaluate the efficacy of topical N-acetyl-cysteine (NAC) therapy in patients with meibomian gland dysfunction (MGD)
AKYOL SALMAN, İlknur +3 more
core +1 more source
From Molecular Targets to Advanced Delivery Systems: Aptamers for Precision Ocular Therapeutics
Advanced Therapeutics, Volume 9, Issue 10, October 2026.Aptamer‐based strategies are revolutionizing ocular disease management through highly specific molecular recognition of disease specific molecular targets. This review systematically integrates therapeutic aptamer sequences, diagnostic aptasensor platforms, and targeted delivery strategies, highlighting design principles, ocular bioavailability ...
Minal Thacker +4 more
wiley +1 more source
Intraductal meibomian gland probing: background, patient selection, procedure, and perspectives
Clinical Ophthalmology, 2019 Steven L Maskin, Sreevardhan AlluriDry Eye and Cornea Treatment Center, Tampa, FL, USAAbstract: Obstructive meibomian gland dysfunction is the most common cause of dry eye.
Maskin SL, Alluri S
doaj
Long‐Term Ocular Outcomes of Dupilumab in Atopic Dermatitis: Results From the BioDay Registry
Clinical and Translational Allergy, Volume 16, Issue 10, October 2026.ABSTRACT Background Dupilumab‐associated ocular surface disease (DAOSD) is the most reported side effect in dupilumab‐treated atopic dermatitis (AD) patients. We investigated the effect of long‐term dupilumab treatment on ocular surface disease (OSD), conjunctival goblet cells (GCs), and tear fluid dupilumab levels and proteins.
Nienke Veldhuis +12 more
wiley +1 more source